Interview with Alex Zhavoronkov, CEO of Insilico Medicine – Speaker at PMWC 2018 Silicon Valley
Q: Everyone is talking about the China’s big push into AI. What is happening in China?...
Q: Everyone is talking about the China’s big push into AI. What is happening in China?...
An example that is likely to become a model, not only for other NICUs, but for efficient whole genome sequencing in the general clinical setting....
Q: Can you describe some of the initial challenges you faced in understanding how the CRISPR system works?...
Q: Can you share some of the latest discoveries in new drugs and diagnostics that scientists at the Helen Diller Family Comprehensive Cancer Center are working on?...
Q: What challenges are there when it comes to defining the commercialization strategy for when marrying a drug with a diagnostics?...
Anil Sethi: “It’s fine to talk about cutting edge immunotherapy, biomarkers for early detection of disease, and the implications of ‘big data’. But there are dirty little secrets surrounding big-data in healthcare…. we’ve got to think much smaller. Small data; N-of-1; The individual. Collected patient...
The startup world is changing! [Link] Startups in “hard sciences” like biology or chemistry are now getting the attention they deserve from big investors and Fortune 500 companies....
Q: What impact will a pay-for-performance model have on healthcare, the patient and physician, the pharmaceutical industry, or the health insurance provider?...
We had a chance to sit down with Dr. Simon Kos, CMO, Microsoft who will be speaking at our upcoming PMWC 2018 Silicon Valley conference this coming January....
Each plays a critical role in shaping the human healthcare system, moving it from a general population approach toward a personalized and patient-centered care model...